JUN KIM: Open Payments
NPI 1073546024 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 21 payments from 5 companies in 2025. Trend: 2023 $716 · 2024 $572 · 2025 $634
Food & beverage: $578Education: $56
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $185 |
| GlaxoSmithKline, LLC. | 12 | $152 |
| Regeneron Healthcare Solutions, Inc. | 4 | $141 |
| AstraZeneca Pharmaceuticals LP | 1 | $135 |
| Optinose US, Inc. | 1 | $22 |
Products named: DUPIXENT, NUCALA, Xhance.
Industry payments across GA — which companies pay providers there.
